Survival in treated hypertension: follow up study after two decades
about
Polymorphisms of the Flavin containing monooxygenase 3 (FMO3) gene do not predispose to essential hypertension in CaucasiansMultivariate risk assessment and risk score cards in hypertensionRisk for Incident Heart Failure: A Subject-Level Meta-Analysis From the Heart "OMics" in AGEing (HOMAGE) Study.Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women.Thiazide diuretics in hypertension.British Hypertension Society guidelines for hypertension management 1999: summarySurvival with treated and well-controlled blood pressure: findings from a prospective cohort studyThe management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future.Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.Essential hypertension: the heart and hypertensionCarcinogenicity of antihypertensive therapy.Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure.Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study.Adverse socioeconomic position across the lifecourse increases coronary heart disease risk cumulatively: findings from the British women's heart and health studyAssociation between childhood and adulthood socioeconomic position and pregnancy induced hypertension: results from the Aberdeen children of the 1950s cohort study.Hypertension treatment and stroke prevention.The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States.Novel antihypertensive agents.Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?Long-term outcome of a large series of patients surgically treated for pheochromocytoma.Do angiotensin II antagonists provide benefits beyond blood pressure reduction?Angiotensin II-receptor antagonist in the treatment of hypertension.Hypertension in young children and neonates.Indapamide sustained release: a review of its use in the treatment of hypertension.The blood pressure lowering potential of sulodexide--a systematic review and meta-analysisEarly detection and management of the high-risk patient with elevated blood pressure.Residual Cardiovascular Risk in Individuals on Blood Pressure-Lowering Treatment.Primary and secondary prevention of stroke by antihypertensive treatment in clinical trials.The Canadian Hypertension Education Program--a unique Canadian initiative.Antihypertensive medications and their effects on lipid metabolism.Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort StudyRole of fetal programming in the development of hypertension.Antihypertensive treatment and stroke prevention: from recent meta-analyses to the PRoFESS trial.High blood pressure: An obscuring misnomer?The epidemiological concept of residual risk.Prevention of heart failure in the elderly: when, where and how to begin?Impact of Visit-to-Visit Variability in Systolic Blood Pressure on Cardiovascular Outcomes in Korean National Health Insurance Service-National Sample Cohort.Use of predictive markers to improve cardiovascular protection.The effects of awareness, treatment and control of hypertension on cardiovascular and all-cause mortality in a community-based population.Risk of coronary events by baseline factors during 28 years follow-up and three periods in a random population sample of men.
P2860
Q24813080-5D5FD8FF-01FB-41FD-BDE6-3F5DEB0235DFQ28219606-780E829D-3E0A-4861-8381-F50EEDB8E0B1Q30234586-F35C631A-5D76-47F2-8A90-A26A65722A6BQ30234618-46CD7FEB-53C6-4C02-8CFB-0FC4647211E1Q33697661-51DED536-3B70-4869-BE04-F9BB127E33B7Q33797387-AD33485A-C064-4CA1-8CDC-77EFFBB9FA01Q33886759-3078BA63-EB29-4F1A-A194-D19A46779E10Q33955304-EACC8431-5C88-4D04-B8F6-BBA02D5959B5Q34299778-F4EF3213-F3BE-444C-BAEE-AB86D8BEF52EQ34371136-50D3EB47-C3FA-4DA5-B31B-7E92AB676F5EQ34633329-C2D2BFEA-31B3-4890-83B1-5D992BCEA4E1Q34634131-7AD0B52D-8132-4900-9E4B-49E6D65FE5A6Q34874543-2B133323-09A2-4F27-B134-6518C10A592BQ35419752-4FA11DD3-2047-4BC7-B7F5-43D8B92159A6Q35572114-A4836DA5-0E7C-4B04-B417-6F30F7969F81Q35649169-5B2C0352-8CFF-45B2-92BA-A428F15E0544Q35826150-6A3B13F0-79E5-4917-B67C-DD6E6970D9EDQ35842537-61F6A600-0E9B-4444-9D2C-7B1D134D86EFQ36060436-05E1E7F7-CFF3-4973-9F00-2BCBDBB6A82FQ36161460-B44CD206-9F1B-4A49-AD71-955749B8F70FQ36195282-79E6548B-633C-44B5-965D-8918CF562136Q36214898-CB047A45-0F55-416B-BC4B-E4A38C6D101EQ36357069-C864151B-6858-4EA4-98D9-1C587CB51961Q36383782-A0F4FFA0-6E3A-4153-9A85-54D4457A060EQ36410118-498A848D-C32A-4D27-9BDB-C08098B84620Q36812763-4FDFD3D6-1FB0-4955-8996-35E2E087A1DFQ36836196-79C2D7B2-621C-44E1-B03A-338B1D59B28EQ36905137-77F15EE0-2908-49F1-B80E-E63102546AFAQ36921844-A0AABB6C-32AE-4ADA-A711-E89B5E616476Q37215444-D96FA06C-453B-4A11-8DF0-BEC09291FC30Q37253234-BB6AE4E9-44B1-465A-B6D0-A3F7A8AAE3F3Q37297358-54DFD783-9A4F-44A1-93DC-8577D6ECDF30Q37551262-E34BCFE4-D04D-4B11-9A21-10DD16D97F4CQ37672895-F8E435DE-A016-47C7-B76B-204D142E7303Q37947160-70F4C205-B11C-40D9-954C-17D37927F7C1Q37978190-ED6D68C1-C788-43F9-BFD3-DA0C0275E0A6Q38774804-825029EF-72A6-4239-8116-53FFB2B5D0F5Q40199205-9973DDA3-F6AE-46D6-9112-102D7ED044E6Q44517758-6430C1D1-91DF-40E2-88E1-B905CACD7CBBQ45058811-8F550671-0A65-48F2-A4B0-9A19115BC26E
P2860
Survival in treated hypertension: follow up study after two decades
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Survival in treated hypertension: follow up study after two decades
@ast
Survival in treated hypertension: follow up study after two decades
@en
type
label
Survival in treated hypertension: follow up study after two decades
@ast
Survival in treated hypertension: follow up study after two decades
@en
prefLabel
Survival in treated hypertension: follow up study after two decades
@ast
Survival in treated hypertension: follow up study after two decades
@en
P2093
P2860
P356
P1433
P1476
Survival in treated hypertension: follow up study after two decades
@en
P2093
L Wilhelmsen
O K Andersson
O Samuelsson
P2860
P304
P356
10.1136/BMJ.317.7152.167
P407
P577
1998-07-01T00:00:00Z